NCT03051282View on ClinicalTrials.gov

Genetic Determinants of ACEI Prodrug Activation

PHASE4RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 1, 2017

Primary Completion Date

January 1, 2026

Study Completion Date

January 1, 2026

Conditions
Healthy Volunteers
Interventions
DRUG

Enalapril

Study participants in both arms will be treated with 10 mg enalapril orally once daily for seven consecutive days

Trial Locations (1)

48109

RECRUITING

University of Michigan, Ann Arbor

All Listed Sponsors
lead

University of Michigan

OTHER